Maple Wang

6.3k citations

9 papers · 1.9k indexed · 4 hit papers · h-index 7

Impact in

Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Viral gastroenteritis research and epidemiology
Animal Science and Zoology top 2%
- Animal Virus Infections Studies

Papers in ⓘ

Infectious Diseases 8
- SARS-CoV-2 and COVID-19 Research 8
- COVID-19 Clinical Research Studies 3
- Viral gastroenteritis research and epidemiology 3
- SARS-CoV-2 detection and testing 2
Animal Science and Zoology 2
- Animal Virus Infections Studies 2

Co-authors: David D. Ho (9 shared papers)Lihong Liu (7 shared papers)Jian Yu (6 shared papers)Yaoxing Huang (7 shared papers)Yicheng Guo (7 shared papers)Zizhang Sheng (7 shared papers)Sho Iketani (4 shared papers)Manoj S. Nair (6 shared papers)
Journals: Nature (2 papers)iScience (1 paper)Science Translational Medicine (1 paper)Cell Host & Microbe (1 paper)Cell Reports (1 paper)
Partner nations: United States Hong Kong Canada

In The Last Decade

Maple Wang

9 papers receiving 1.8k citations

Hit Papers

align trajectories log scale

Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5 2022 · 433 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Nature
2022 Cell
2022 Nature
2021 Cell Host & Microbe

Peers

Countries citing papers authored by Maple Wang

Since Specialization

Citations

This map shows the geographic impact of Maple Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maple Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maple Wang more than expected).

Fields of papers citing papers by Maple Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maple Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maple Wang. The network helps show where Maple Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Maple Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Maple Wang Line = papers co-authored together Maple Wang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work
1	Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants Cell ·Qian Wang, Sho Iketani, Zhiteng Li, Liyuan Liu, Yicheng Guo, Yiming Huang, Anthony Bowen, Michael Liu, Maple Wang, Jian Yu, Riccardo Valdez, Adam S. Lauring, Zizhang Sheng, Harris H. Wang, Aubree Gordon, Lihong Liu, David D. Ho Hit paper breakdown →	2022	495
2	Antibody evasion properties of SARS-CoV-2 Omicron sublineages Nature ·Sho Iketani, Lihong Liu, Yicheng Guo, Liyuan Liu, Jasper Fuk‐Woo Chan, Yiming Huang, Maple Wang, Yang Luo, Jian Yu, Hin Chu, Kenn K.-H. Chik, Terrence T.-T. Yuen, Michael T. Yin, Magdalena E. Sobieszczyk, Yaoxing Huang, Kwok‐Yung Yuen, Harris H. Wang, Zizhang Sheng, David D. Ho Hit paper breakdown →	2022	478
3	Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5 Nature ·Qian Wang, Yicheng Guo, Sho Iketani, Manoj S. Nair, Zhiteng Li, Hiroshi Mohri, Maple Wang, Jian Yu, Anthony Bowen, Jennifer Y. Chang, Jayesh Shah, Nadia Nguyen, Zhiwei Chen, Kathrine Meyers, Michael T. Yin, Magdalena E. Sobieszczyk, Zizhang Sheng, Yaoxing Huang, Lihong Liu, David D. Ho Hit paper breakdown →	2022	433
4	Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization Cell Host & Microbe ·Pengfei Wang, Ryan G. Casner, Manoj S. Nair, Maple Wang, Jian Yu, Gabriele Cerutti, Lihong Liu, Peter D. Kwong, Yaoxing Huang, Lawrence Shapiro, David D. Ho Hit paper breakdown →	2021	390
5	Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain Cell Reports ·Gabriele Cerutti, Yicheng Guo, Pengfei Wang, Manoj S. Nair, Maple Wang, Yaoxing Huang, Jian Yu, Lihong Liu, Phinikoula S. Katsamba, Fabiana Bahna, Eswar R. Reddem, Peter D. Kwong, David D. Ho, Zizhang Sheng, Lawrence Shapiro	2021	42
6	A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses Emerging Microbes & Infections ·Pengfei Wang, Ryan G. Casner, Manoj S. Nair, Jian Yu, Yicheng Guo, Maple Wang, Jasper Fuk‐Woo Chan, Gabriele Cerutti, Sho Iketani, Lihong Liu, Zizhang Sheng, Zhiwei Chen, Kwok‐Yung Yuen, Peter D. Kwong, Yaoxing Huang, Lawrence Shapiro, David D. Ho	2021	26
7	A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo Science Translational Medicine ·Clare Burn Aschner, Krithika Muthuraman, Iga Kucharska, Hong Cui, Katherine Prieto, Manoj S. Nair, Maple Wang, Yaoxing Huang, Natasha Christie-Holmes, Betty Poon, Jessica Lam, Azmiri Sultana, Robert Kozak, Samira Mubareka, John L. Rubinstein, Edurne Rujas, Bebhinn Treanor, David D. Ho, Arif Jetha, Jean‐Philippe Julien	2023	11
8	Changes in serum-neutralizing antibody potency and breadth post-SARS-CoV-2 mRNA vaccine boost iScience ·Manoj S. Nair, Ruy M. Ribeiro, Maple Wang, Anthony Bowen, Lihong Liu, Yicheng Guo, Jennifer Y. Chang, Pengfei Wang, Zizhang Sheng, Magdalena E. Sobieszczyk, Alan S. Perelson, Yaoxing Huang, David D. Ho	2023	3
9	An optimized thermodynamics integration protocol for identifying beneficial mutations in antibody design Frontiers in Immunology ·Zizhang Sheng, Jude Bimela, Maple Wang, Zhiteng Li, Yicheng Guo, David D. Ho	2023	2

About Maple Wang

Maple Wang is a scholar working on Infectious Diseases, Animal Science and Zoology, Radiology, Nuclear Medicine and Imaging, Biotechnology and Immunology, having authored 9 papers that have together received 1.9k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Viral gastroenteritis research and epidemiology (3 papers), Bacillus and Francisella bacterial research (2 papers), SARS-CoV-2 detection and testing (2 papers), Animal Virus Infections Studies (2 papers) and Viral Infections and Immunology Research (1 paper). The work is most often cited by research in Infectious Diseases (1.7k citations), Animal Science and Zoology (243 citations), Modeling and Simulation (90 citations), Health (90 citations) and Radiology, Nuclear Medicine and Imaging (207 citations). Maple Wang has collaborated with scholars based in United States, Hong Kong and Canada. Frequent co-authors include David D. Ho, Lihong Liu, Jian Yu, Yaoxing Huang, Yicheng Guo, Zizhang Sheng, Sho Iketani, Manoj S. Nair, Harris H. Wang and Yiming Huang. Their work appears in journals such as Nature, iScience, Science Translational Medicine, Cell Host & Microbe and Cell Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact